Turnaround Time:5-7 business days
Multiple compounding factors have fuelled the opposition to the relevance of the Mauve Factor to mental health disorders. One area is the incorrect chemical identification of the Mauve Factor and the subsequent erroneous naming (kryptopyrrole) of this neurotoxic compound. Kryptopyrrole is the term that the Pfeiffer Centre has used in the past for the Mauve Factor and this term has been in use for more than 20 years. However, it has recently come to the attention of those involved in this area of research that the term ‘kryptopyrrole’ is scientifically inaccurate, and the Mauve Factor has been identified as hydroxyhemopyrrolin-2-one (HPL).
- Abdominal pain
- Impotence in males
- Irregular periods
- Anxiety Morning nausea
- Attention Deficit/Hyperactivity
NOTICE TO PATIENTS
NutriPATH practices in the usual practitioner-referral system for pathology laboratories. Patients are highly recommended to seek the supervision and guidance of a qualified healthcare practitioner for the interpretation of any lab results and associated information. NutriPATH can offer assistance in locating a suitable practitioner.